Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth K Tanabe

Showing results (11-20 of 205) with videos related to

Pageof 21
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Patient selection, resection, and outcomes for hepatocellular carcinomaClaudius Conrad, Kenneth K Tanabe
Annals of Surgical Oncology|January 20, 2023
Adjuvant Systemic Therapy for High-Risk MelanomaSonia Cohen, Kenneth K Tanabe
Annals of Surgical Oncology|July 4, 2003
Viral oncolysis for malignant liver tumorsJohn T Mullen, Kenneth K Tanabe
Surgical Oncology Clinics of North America|December 19, 2002
Introduction to cancer gene therapyJames C Cusack, Kenneth K Tanabe
Journal of Hepatocellular Carcinoma|July 20, 2017
Hepatocellular carcinoma: early-stage management challengesDerek J Erstad, Kenneth K Tanabe
The Virtual Mentor : VM|December 11, 2012
Is it ethical to send patients to low-volume hospitals for cancer surgery?Timothy M Pawlik, Kenneth K Tanabe
Annals of Surgical Oncology|February 22, 2019
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular CarcinomaDerek J Erstad, Kenneth K Tanabe
Annals of Surgical Oncology|March 16, 2007
Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors?Sam S Yoon, Kenneth K Tanabe
The Oncologist|April 19, 2002
Viral oncolysisJohn T Mullen, Kenneth K Tanabe
Annals of Surgical Oncology|May 22, 2019
ASO Author Reflections: A New Look at the Clinical Significance of MVI in Hepatocellular CarcinomaDerek J Erstad, Kenneth K Tanabe
Pageof 21

Showing results (11-20 of 205) with videos related to

Sort By:
Pageof 21
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Patient selection, resection, and outcomes for hepatocellular carcinomaClaudius Conrad, Kenneth K Tanabe
Annals of Surgical Oncology|January 20, 2023
Adjuvant Systemic Therapy for High-Risk MelanomaSonia Cohen, Kenneth K Tanabe
Annals of Surgical Oncology|July 4, 2003
Viral oncolysis for malignant liver tumorsJohn T Mullen, Kenneth K Tanabe
Surgical Oncology Clinics of North America|December 19, 2002
Introduction to cancer gene therapyJames C Cusack, Kenneth K Tanabe
Journal of Hepatocellular Carcinoma|July 20, 2017
Hepatocellular carcinoma: early-stage management challengesDerek J Erstad, Kenneth K Tanabe
The Virtual Mentor : VM|December 11, 2012
Is it ethical to send patients to low-volume hospitals for cancer surgery?Timothy M Pawlik, Kenneth K Tanabe
Annals of Surgical Oncology|February 22, 2019
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular CarcinomaDerek J Erstad, Kenneth K Tanabe
Annals of Surgical Oncology|March 16, 2007
Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors?Sam S Yoon, Kenneth K Tanabe
The Oncologist|April 19, 2002
Viral oncolysisJohn T Mullen, Kenneth K Tanabe
Annals of Surgical Oncology|May 22, 2019
ASO Author Reflections: A New Look at the Clinical Significance of MVI in Hepatocellular CarcinomaDerek J Erstad, Kenneth K Tanabe
Pageof 21